Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating anthracycline cardiotoxicity associated single nucleotide polymorphisms in a paediatric cohort with early onset cardiomyopathy
Timothy N. McOwan, Lauren Craig, Anne Tripdayonis, et al.
Cardio-Oncology (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

Organoids are not organs: Sources of variation and misinformation in organoid biology
Kim B. Jensen, Melissa H. Little
Stem Cell Reports (2023) Vol. 18, Iss. 6, pp. 1255-1270
Open Access | Times Cited: 45
Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective
Anna Singleton, Julie Redfern, Abbey Diaz, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 5, pp. 564-575
Open Access | Times Cited: 6
Role of GPCR Signaling in Anthracycline-Induced Cardiotoxicity
Nimish Biswal, Ritika Harish, Mohsin H. K. Roshan, et al.
Cells (2025) Vol. 14, Iss. 3, pp. 169-169
Open Access
Genetic Susceptibility and Mechanisms Underlying the Pathogenesis of Anthracycline-Associated Cardiotoxicity
Yonghe Ding, Ke Du, Yujuan Niu, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 13
The genetic underpinnings of anthracycline‐induced cardiomyopathy predisposition
Amy M. Berkman, Michelle A.T. Hildebrandt, Andrew P. Landstrom
Clinical Genetics (2021) Vol. 100, Iss. 2, pp. 132-143
Open Access | Times Cited: 13
Prognostic Factors for Cardiotoxicity among Children with Cancer: Definition, Causes, and Diagnosis with Omics Technologies
Kondylia Antoniadi, Νikolaos S. Τhomaidis, Petros Nihoyannopoulos, et al.
Diagnostics (2023) Vol. 13, Iss. 11, pp. 1864-1864
Open Access | Times Cited: 3
Leveraging Clinical Informatics Tools to Extract Cumulative Anthracycline Exposure, Measure Cardiovascular Outcomes, and Assess Guideline Adherence for Children With Cancer
David H. Noyd, Amy M. Berkman, Claire B. Howell, et al.
JCO Clinical Cancer Informatics (2021), Iss. 5, pp. 1062-1075
Open Access | Times Cited: 7
Prognostic Factors for Cardiotoxicity Among Children With Cancer: Definition, Causes and Diagnosis With Omics Technologies
Kondylia Antoniadi, Νikolaos S. Τhomaidis, Petros Nihoyannopoulos, et al.
(2023)
Open Access | Times Cited: 2
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Aurora Gómez-Vecino, Roberto Corchado‐Cobos, Adrián Blanco‐Gómez, et al.
Cells (2023) Vol. 12, Iss. 15, pp. 1956-1956
Open Access | Times Cited: 1
Modeling Susceptibility to Cardiotoxicity in Cancer Therapy Using Human iPSC-Derived Cardiac Cells and Systems Biology
McKay Mullen, Wilson Lek Wen Tan, June‐Wha Rhee, et al.
Heart Failure Clinics (2022) Vol. 18, Iss. 3, pp. 335-347
Open Access | Times Cited: 1
Mitoxantrone/anthracyclines

Reactions Weekly (2020) Vol. 1810, Iss. 1, pp. 141-141
Closed Access
Page 1

Scroll to top